View in EDS HTML Full Text PDF Full Text

Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population.

Saved in:
Bibliographic Details
Title: Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population.
Authors: Walpole, Imogen1 (AUTHOR) irwalpole@gmail.com, Lee, Belinda1,2,3 (AUTHOR), Shapiro, Jeremy4,5 (AUTHOR), Thomson, Benjamin6,7 (AUTHOR), Lipton, Lara4,7,8 (AUTHOR), Ananda, Sumitra7,8 (AUTHOR), Usatoff, Val4,8 (AUTHOR), Mclachlan, Sue‐Ann3,9 (AUTHOR), Knowles, Brett7,9 (AUTHOR), Fox, Adrian9,10 (AUTHOR), Wong, Rachel2,5,10,11 (AUTHOR), Cooray, Prasad12 (AUTHOR), Burge, Matthew13 (AUTHOR), Clarke, Kate14 (AUTHOR), Pattison, Sharon15 (AUTHOR), Nikfarjam, Mehrdad3,16,17 (AUTHOR), Tebbutt, Niall16 (AUTHOR), Harris, Marion18 (AUTHOR), Nagrial, Adnan19 (AUTHOR), Zielinski, Rob20,21,22 (AUTHOR)
Source: Asia Pacific Journal of Clinical Oncology. Feb2023, Vol. 19 Issue 1, p214-225. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17437555
DOI:10.1111/ajco.13807